Cargando…

Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients

Familial hemophagocytic lymphohistiocytosis Type 2 (FHL2) associated central nervous system (CNS) involvement is less understood in children, especially when considering neurologic manifestations as part of the initial presentation. We conducted a retrospective review of the clinical manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Wei-xing, Yang, Xin-ying, Li, Jiu-wei, Gong, Shuai, Wu, Yun, Zhang, Wei-hua, Han, Tong-li, Zhuo, Xiu-wei, Ding, Chang-hong, Fang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064636/
https://www.ncbi.nlm.nih.gov/pubmed/32194620
http://dx.doi.org/10.3389/fgene.2020.00126
_version_ 1783504913704157184
author Feng, Wei-xing
Yang, Xin-ying
Li, Jiu-wei
Gong, Shuai
Wu, Yun
Zhang, Wei-hua
Han, Tong-li
Zhuo, Xiu-wei
Ding, Chang-hong
Fang, Fang
author_facet Feng, Wei-xing
Yang, Xin-ying
Li, Jiu-wei
Gong, Shuai
Wu, Yun
Zhang, Wei-hua
Han, Tong-li
Zhuo, Xiu-wei
Ding, Chang-hong
Fang, Fang
author_sort Feng, Wei-xing
collection PubMed
description Familial hemophagocytic lymphohistiocytosis Type 2 (FHL2) associated central nervous system (CNS) involvement is less understood in children, especially when considering neurologic manifestations as part of the initial presentation. We conducted a retrospective review of the clinical manifestations and genetic abnormality of four Han Chinese children with FHL2 who were patients at the neurology department of Beijing Children’s Hospital from November 2015 to October 2018. These four patients initially manifested CNS symptoms in their disease presentation, and all four patients were misdiagnosed as having ademyelinating disease, such as acute disseminated encephalomyelitis and multiple sclerosis. Given these misdiagnoses, it is important that general physicians and pediatricians maintain awareness of the possibility of FHL2 as a differential diagnosis. These four cases included neurologic manifestations including seizures, ataxia, spasticity, gait disorder, and coma. Bilateral abnormal signals in the cerebrum, including in white matter, gray matter, and junctions were discovered. Enhanced magnetic resonance imaging (MRI) in these patients showed spot or ring enhancement and/or hemorrhage. These patients all possessed a compound heterozygote mutation PRF1 gene. Whole exome sequencing analysis revealed seven different mutations (three novel mutations) spread over the PRF1 gene and a heterozygous missense mutation c.1349C > T [p.T450M] that was present in two patients. Three novel mutations, c.634T > C[p.Y212H], c.1083_1094del[p.361_364del], and c.1306G > T [p.D436Y], were discovered and through in silico analysis were discovered to be deleterious. Neurologic manifestations were the initial symptoms of FHL2 in these patients in addition to the expected leukopenia and hepatosplenomegaly. Whole exome sequencing of PRF1 for patients with similar presentations would facilitate prompt and accurate diagnosis and treatment.
format Online
Article
Text
id pubmed-7064636
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70646362020-03-19 Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients Feng, Wei-xing Yang, Xin-ying Li, Jiu-wei Gong, Shuai Wu, Yun Zhang, Wei-hua Han, Tong-li Zhuo, Xiu-wei Ding, Chang-hong Fang, Fang Front Genet Genetics Familial hemophagocytic lymphohistiocytosis Type 2 (FHL2) associated central nervous system (CNS) involvement is less understood in children, especially when considering neurologic manifestations as part of the initial presentation. We conducted a retrospective review of the clinical manifestations and genetic abnormality of four Han Chinese children with FHL2 who were patients at the neurology department of Beijing Children’s Hospital from November 2015 to October 2018. These four patients initially manifested CNS symptoms in their disease presentation, and all four patients were misdiagnosed as having ademyelinating disease, such as acute disseminated encephalomyelitis and multiple sclerosis. Given these misdiagnoses, it is important that general physicians and pediatricians maintain awareness of the possibility of FHL2 as a differential diagnosis. These four cases included neurologic manifestations including seizures, ataxia, spasticity, gait disorder, and coma. Bilateral abnormal signals in the cerebrum, including in white matter, gray matter, and junctions were discovered. Enhanced magnetic resonance imaging (MRI) in these patients showed spot or ring enhancement and/or hemorrhage. These patients all possessed a compound heterozygote mutation PRF1 gene. Whole exome sequencing analysis revealed seven different mutations (three novel mutations) spread over the PRF1 gene and a heterozygous missense mutation c.1349C > T [p.T450M] that was present in two patients. Three novel mutations, c.634T > C[p.Y212H], c.1083_1094del[p.361_364del], and c.1306G > T [p.D436Y], were discovered and through in silico analysis were discovered to be deleterious. Neurologic manifestations were the initial symptoms of FHL2 in these patients in addition to the expected leukopenia and hepatosplenomegaly. Whole exome sequencing of PRF1 for patients with similar presentations would facilitate prompt and accurate diagnosis and treatment. Frontiers Media S.A. 2020-03-04 /pmc/articles/PMC7064636/ /pubmed/32194620 http://dx.doi.org/10.3389/fgene.2020.00126 Text en Copyright © 2020 Feng, Yang, Li, Gong, Wu, Zhang, Han, Zhuo, Ding and Fang http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Feng, Wei-xing
Yang, Xin-ying
Li, Jiu-wei
Gong, Shuai
Wu, Yun
Zhang, Wei-hua
Han, Tong-li
Zhuo, Xiu-wei
Ding, Chang-hong
Fang, Fang
Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title_full Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title_fullStr Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title_full_unstemmed Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title_short Neurologic Manifestations as Initial Clinical Presentation of Familial Hemophagocytic Lymphohistiocytosis Type2 Due to PRF1 Mutation in Chinese Pediatric Patients
title_sort neurologic manifestations as initial clinical presentation of familial hemophagocytic lymphohistiocytosis type2 due to prf1 mutation in chinese pediatric patients
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064636/
https://www.ncbi.nlm.nih.gov/pubmed/32194620
http://dx.doi.org/10.3389/fgene.2020.00126
work_keys_str_mv AT fengweixing neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT yangxinying neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT lijiuwei neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT gongshuai neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT wuyun neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT zhangweihua neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT hantongli neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT zhuoxiuwei neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT dingchanghong neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients
AT fangfang neurologicmanifestationsasinitialclinicalpresentationoffamilialhemophagocyticlymphohistiocytosistype2duetoprf1mutationinchinesepediatricpatients